Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
<p>Abstract</p> <p>Background</p> <p>Hepatocellular carcinoma (HCC) is an aggressive cancer, and is the third leading cause of cancer death worldwide. Standard therapy is ineffective partly because HCC is intrinsically resistant to conventional chemotherapy. Its poor pr...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-09-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/8/1/76 |
id |
doaj-309e7e3a6add45fdacfce634569d7ee3 |
---|---|
record_format |
Article |
spelling |
doaj-309e7e3a6add45fdacfce634569d7ee32020-11-25T00:57:16ZengBMCMolecular Cancer1476-45982009-09-01817610.1186/1476-4598-8-76Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cellsGrepper SusanChua Mei-SzeWei WeiSo Samuel K<p>Abstract</p> <p>Background</p> <p>Hepatocellular carcinoma (HCC) is an aggressive cancer, and is the third leading cause of cancer death worldwide. Standard therapy is ineffective partly because HCC is intrinsically resistant to conventional chemotherapy. Its poor prognosis and limited treatment options make it critical to develop novel and selective chemotherapeutic agents. Since the Wnt/β-catenin pathway is essential in HCC carcinogenesis, we studied the inhibition of Wnt-1-mediated signaling as a potential molecular target in HCC.</p> <p>Results</p> <p>We demonstrated that Wnt-1 is highly expressed in human hepatoma cell lines and a subgroup of human HCC tissues compared to paired adjacent non-tumor tissues. An anti-Wnt-1 antibody dose-dependently decreased viability and proliferation of Huh7 and Hep40 cells over-expressing Wnt-1 and harboring wild type β-catenin, but did not affect normal hepatocytes with undetectable Wnt-1 expression. Apoptosis was also observed in Huh7 and Hep40 cells after treatment with anti-Wnt-1 antibody. In these two cell lines, the anti-Wnt-1 antibody decreased β-catenin/Tcf4 transcriptional activities, which were associated with down-regulation of the endogenous β-catenin/Tcf4 target genes c-Myc, cyclin D1, and survivin. Intratumoral injection of anti-Wnt-1 antibody suppressed <it>in vivo </it>tumor growth in a Huh7 xenograft model, which was also associated with apoptosis and reduced c-Myc, cyclin D1, and survivin expressions.</p> <p>Conclusion</p> <p>Our results suggest that Wnt-1 is a survival factor for HCC cells, and that the blockade of Wnt-1-mediated signaling may offer a potential pathway-specific therapeutic strategy for the treatment of a subgroup of HCC that over-expresses Wnt-1.</p> http://www.molecular-cancer.com/content/8/1/76 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Grepper Susan Chua Mei-Sze Wei Wei So Samuel K |
spellingShingle |
Grepper Susan Chua Mei-Sze Wei Wei So Samuel K Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells Molecular Cancer |
author_facet |
Grepper Susan Chua Mei-Sze Wei Wei So Samuel K |
author_sort |
Grepper Susan |
title |
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells |
title_short |
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells |
title_full |
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells |
title_fullStr |
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells |
title_full_unstemmed |
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells |
title_sort |
blockade of wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells |
publisher |
BMC |
series |
Molecular Cancer |
issn |
1476-4598 |
publishDate |
2009-09-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Hepatocellular carcinoma (HCC) is an aggressive cancer, and is the third leading cause of cancer death worldwide. Standard therapy is ineffective partly because HCC is intrinsically resistant to conventional chemotherapy. Its poor prognosis and limited treatment options make it critical to develop novel and selective chemotherapeutic agents. Since the Wnt/β-catenin pathway is essential in HCC carcinogenesis, we studied the inhibition of Wnt-1-mediated signaling as a potential molecular target in HCC.</p> <p>Results</p> <p>We demonstrated that Wnt-1 is highly expressed in human hepatoma cell lines and a subgroup of human HCC tissues compared to paired adjacent non-tumor tissues. An anti-Wnt-1 antibody dose-dependently decreased viability and proliferation of Huh7 and Hep40 cells over-expressing Wnt-1 and harboring wild type β-catenin, but did not affect normal hepatocytes with undetectable Wnt-1 expression. Apoptosis was also observed in Huh7 and Hep40 cells after treatment with anti-Wnt-1 antibody. In these two cell lines, the anti-Wnt-1 antibody decreased β-catenin/Tcf4 transcriptional activities, which were associated with down-regulation of the endogenous β-catenin/Tcf4 target genes c-Myc, cyclin D1, and survivin. Intratumoral injection of anti-Wnt-1 antibody suppressed <it>in vivo </it>tumor growth in a Huh7 xenograft model, which was also associated with apoptosis and reduced c-Myc, cyclin D1, and survivin expressions.</p> <p>Conclusion</p> <p>Our results suggest that Wnt-1 is a survival factor for HCC cells, and that the blockade of Wnt-1-mediated signaling may offer a potential pathway-specific therapeutic strategy for the treatment of a subgroup of HCC that over-expresses Wnt-1.</p> |
url |
http://www.molecular-cancer.com/content/8/1/76 |
work_keys_str_mv |
AT greppersusan blockadeofwnt1signalingleadstoantitumoreffectsinhepatocellularcarcinomacells AT chuameisze blockadeofwnt1signalingleadstoantitumoreffectsinhepatocellularcarcinomacells AT weiwei blockadeofwnt1signalingleadstoantitumoreffectsinhepatocellularcarcinomacells AT sosamuelk blockadeofwnt1signalingleadstoantitumoreffectsinhepatocellularcarcinomacells |
_version_ |
1725224985056772096 |